Global Venous Thromboembolism Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Venous Thromboembolism Treatment Market is presumed to reach the market size of nearly USD 2809.58 Million by 2032 from USD 1273.49 Million in 2023 with a CAGR of 9.19% under the study period 2024-2032.

Venous thromboembolism (VTE) is a medical condition where blood clot is formed in the deep veins of the upper and lower extremities, resulting in deep vein thrombosis (DVT). When these blood clots reach the lungs, it is known as pulmonary embolism (PE). It leads to blockage of one of the pulmonary arteries. VTE is an underdiagnosed but serious condition, to the extent that it can even cause death and disability. The available treatment options for VTE are thrombolytic therapy and anticoagulant drugs, acting as blood thinners. Venous thromboembolism can also be treated with certain mechanical devices, such as, compression devices, thrombectomy systems and filters.

MARKET DYNAMICS

The key drivers behind global venous thromboembolism treatment market growth are increasing incidence of VTE and increasing awareness about the existing treatment options. Introduction of new VTE treatment devices, increasing the number of treatment choices for patients will contribute significantly towards VTE treatment market. Furthermore, technological advancements in VTE treatment, such as, development of heparins and associated inhibitors with low molecular weight are expected to bring lucrative growth opportunities for VTE market. However, strict rules and regulations related to approval and adoption of newly launched drugs and therapies and complications associated with VTE drugs may hamper the growth of venous thromboembolism treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Venous Thromboembolism Treatment. The growth and trends of Venous Thromboembolism Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Venous Thromboembolism Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device

Compression System
Thrombectomy Systems
IVC Filters
Stockings
Others

By Application

Deep Vein Thrombosis
Pulmonary Embolism

By End-use

Hospitals
Catheterization Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Venous Thromboembolism Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Venous Thromboembolism Treatment market include Boston Scientific Corporation, AngioDynamics, Cardinal Health, Covidien, Daesung Maref, Cook Medical, Argon Medical Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215191

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. VENOUS THROMBOEMBOLISM TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Device
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY DEVICE

5.1. Overview By Device
5.2. Historical and Forecast Data Analysis By Device
5.3. Compression System Historic and Forecast Sales By Regions
5.4. Thrombectomy Systems Historic and Forecast Sales By Regions
5.5. IVCFilters Historic and Forecast Sales By Regions
5.6. Stockings Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Deep Vein Thrombosis Historic and Forecast Sales By Regions
6.4. Pulmonary Embolism Historic and Forecast Sales By Regions

7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Catheterization Laboratories Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE VENOUS THROMBOEMBOLISM TREATMENT COMPANIES

9.1. Venous Thromboembolism Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AngioDynamics
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Cardinal Health
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Covidien
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Daesung Maref
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Cook Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Argon Medical Products
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies